Case Report
BibTex RIS Cite

Post-transplant Lymphoproliferative Disorder Following Kidney Transplantation,

Year 2022, Volume: 4 - Supplement 1, 158 - 159, 01.04.2022
https://doi.org/10.46310/tjim.1073449

Abstract

Posttransplant lymphoproliferative diseases are complications that develop after solid organ transplantation. Primary EBV infection is one of the most important risk factors. After deceased kidney transplantation, we presented a young male patient diagnosed with diffuse large B-cell lymphoma.

Project Number

1

References

  • Maksten EF, Vase MØ, Kampmann J, d’Amore F, Møller MB, Strandhave C, Bendix K, Bistrup C, Thiesson HC, Søndergaard E, Hamilton-Dutoit S, Jespersen B. Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study. Transpl Int. 2016 Apr;29(4):483- 93. doi: 10.1111/tri.12744.
  • Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Transpl Int. 2007 Mar;20(3):207-18. doi: 10.1111/j.1432- 2277.2006.00416.x.
  • Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): Risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013 Sep;8(3):173-83. doi: 10.1007/s11899-013-0162-5.
  • Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant. 2013 Feb;13 Suppl 3:41-54; quiz 54. doi: 10.1111/ajt.12004.
  • Hutton B, Joseph L, Yazdi F, Tetzlaff J, Hersi M, Kokolo M, Fergusson N, Bennett A, Buenaventura C, Fergusson D, Tricco A, Strauss S, Moher D, Knoll G. Checking whether there is an increased risk of post-transplant lymphoproliferative disorder and other cancers with specific modern immunosuppression regimens in renal transplantation: protocol for a network meta- analysis of randomized and observational studies. Syst Rev. 2014 Feb 22;3:16. doi: 10.1186/2046-4053-3-16.
Year 2022, Volume: 4 - Supplement 1, 158 - 159, 01.04.2022
https://doi.org/10.46310/tjim.1073449

Abstract

Project Number

1

References

  • Maksten EF, Vase MØ, Kampmann J, d’Amore F, Møller MB, Strandhave C, Bendix K, Bistrup C, Thiesson HC, Søndergaard E, Hamilton-Dutoit S, Jespersen B. Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study. Transpl Int. 2016 Apr;29(4):483- 93. doi: 10.1111/tri.12744.
  • Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Transpl Int. 2007 Mar;20(3):207-18. doi: 10.1111/j.1432- 2277.2006.00416.x.
  • Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): Risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013 Sep;8(3):173-83. doi: 10.1007/s11899-013-0162-5.
  • Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant. 2013 Feb;13 Suppl 3:41-54; quiz 54. doi: 10.1111/ajt.12004.
  • Hutton B, Joseph L, Yazdi F, Tetzlaff J, Hersi M, Kokolo M, Fergusson N, Bennett A, Buenaventura C, Fergusson D, Tricco A, Strauss S, Moher D, Knoll G. Checking whether there is an increased risk of post-transplant lymphoproliferative disorder and other cancers with specific modern immunosuppression regimens in renal transplantation: protocol for a network meta- analysis of randomized and observational studies. Syst Rev. 2014 Feb 22;3:16. doi: 10.1186/2046-4053-3-16.
There are 5 citations in total.

Details

Primary Language English
Subjects ​Internal Diseases
Journal Section Case Reports
Authors

Ömer Candar This is me 0000-0001-7602-6926

Tuğçe Zor Turna 0000-0002-1349-8966

Project Number 1
Publication Date April 1, 2022
Submission Date February 20, 2022
Acceptance Date March 9, 2022
Published in Issue Year 2022 Volume: 4 - Supplement 1

Cite

EndNote Candar Ö, Zor Turna T (April 1, 2022) Post-transplant Lymphoproliferative Disorder Following Kidney Transplantation,. Turkish Journal of Internal Medicine 4 158–159.

e-ISSN: 2687-4245 

Turkish Journal of Internal Medicine, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png
2024 -TJIM.org